How to Buy Perspective Therapeutics Stock
Perspective Therapeutics Inc
IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices.
Perspective Therapeutics stock last closed at $1.47, up 2.8% from the previous day, and has increased 122.73% in one year. It has overperformed other stocks in the Medical Devices industry by 1.39 percentage points. Perspective Therapeutics stock is currently +617.07% from its 52-week low of $0.21, and -8.13% from its 52-week high of $1.60.
At the moment, there are 586.92M shares of CATX outstanding. The market capitalization of CATX is $862.77M. In the last 24 hours, 5.05M CATX shares were traded.
How to Buy Perspective Therapeutics Stock
Wondering how to invest in Perspective Therapeutics stock? Here's how.
- Decide where to buy Perspective Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Perspective Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Pick your method of payment and add your info.
- Evaluate Perspective Therapeutics stock: The Perspective Therapeutics ticker symbol is CATX. Is Perspective Therapeutics stock a good investment? Should you buy shares of CATX? How do CATX's underlying business fundamentals look? Do top analysts think Perspective Therapeutics is a good buy? Why has CATX's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if CATX is a good stock to buy).
- Make your CATX buy order: Decide if you will purchase CATX shares at the current market price or use a limit order to purchase CATX shares at a specific price.
- Get updates on your CATX position: Create a watchlist to keep track of your investment in Perspective Therapeutics shares.
Step 1: Decide where to buy Perspective Therapeutics stock
You need an online brokerage account in order to access the NYSEMKT market and buy CATX shares.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Real Estate, New York to London — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal information so you can buy CATX stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to open your new brokerage account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have filled out your info on a investment app, you can securely and quickly fund your account:
Check out the tutorial below to see the process of transferring funds into your investment account.
Step 4: Evaluate Perspective Therapeutics stock
Once you have decided on the best place to buy Perspective Therapeutics stock, it's critical to research their stock before you invest, so you can understand the risk and opportunity.
Perspective Therapeutics shares at a glance
CATX Zen Score
WallStreetZen was built to help part-time investors perform better fundamental analysis.
You can see all of the due diligence checks on CATX's stock page.
What is the fair value of CATX stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CATX's intrinsic value.
Using relative valuations metrics:
- CATX could be overvalued based on its P/B ratio of 11.48x, relative to Medical Devices industry P/B ratio of 3.63x
You can access more valuation research on CATX's stock here.
A quick look at CATX Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the CATX balance sheet.
- There are more short-term assets than long-term liabilities on the CATX balance sheet.
- CATX has a low debt to equity ratio of 0.3.
Failed Financial Due Diligence Checks:
- CATX has $9.42M in cash and short term investments. This is not enough to cover its annual cash burn of $37.99M.
- CATX profit margin has gone down from 200% to -3,243.2% in the past year.
- Total CATX debt is higher than 5 years ago, relative to shareholder equity.
- CATX has cash burn of 37985000. It does not have enough cash and short-term investments to cover this.
Is CATX stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 3 Equities analysts who track CATX, the consensus analyst rating on Perspective Therapeutics is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Perspective Therapeutics stock forecast page.
CATX Technical Indicators
CATX Growth Metrics
Last year, CATX revenue was $1.43M. Over the last 5 year, CATX's revenue has grown by -26.4% per year. This was slower than the Medical Devices industry average of 13.47%.
You can analyze CATX's earnings and revenue performance here.
Latest Insiders Trades at CATX
Over the past year, insiders at CATX have bought more shares than they have sold.
Lantheus Alpha Therapy LLC, 10% Owner of CATX, was the latest CATX insider to buy. They bought $57,409,487.05 worth of CATX shares on Mar 6, 2024.
Research more about who owns CATX stock here.
Does CATX stock generate passive income?
No, Perspective Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about CATX
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your CATX buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, place a limit order.
Hit the Open button and your broker will execute the order.
If you need more help buying stocks on eToro, watch the helpful video below:
Step 6: Get updates on your CATX position
Now that you own some CATX stock, you'll want to stay up-to-date on your new company.
Create a watchlist to track the latest developments regarding your CATX stock.
CATX Feed
How to Buy Stock in Perspective Therapeutics
To summarize, here are the 6 steps for buying Perspective Therapeutics stock:
- Decide where to buy Perspective Therapeutics stock
- Sign up for your brokerage account
- Deposit money your investment account
- Evaluate Perspective Therapeutics stock
- Make your CATX buy order
- Get updates on your CATX position
If you are looking for a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your new investment in Perspective Therapeutics, add CATX to your watchlist below.
More "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.